MDR affects cancer treatment by making standard chemotherapy regimens less effective. Patients with MDR tumors often experience relapse and have a poorer prognosis. The presence of MDR limits the available treatment options and necessitates the development of alternative strategies, such as higher drug doses, combination therapies, or the use of novel agents designed to bypass or inhibit the resistance mechanisms.
